Instrument Inactif

Communiqués Albany Molecular Research, Inc.

Actions

US0124231095

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17/01/18	PU
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04/01/18	PU
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19/12/17	PU
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30/11/17	PU
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09/11/17	PU
Albany Molecular Research : AMRI to Exhibit and Present at MD&M Minneapolis 2017	02/11/17	PU
Albany Molecular Research : AMRI Appoints Paul Feuerman as Senior Vice President General Counsel and Head of Busine...	31/10/17	PU
Robbins Geller Rudman & Dowd LLP : Files Class Action Suit against Albany Molecular Research, Inc.	25/10/17	BU
Albany Molecular Research : AMRI to Highlight Sterile Manufacturing Capacity Expansion, New Technologies at CPhI	23/10/17	PU
Albany Molecular Research : AMRI Launches Stand-Alone Service; Expanding Solutions for Impurity Analysis and Toxico...	12/10/17	PU
Albany Molecular Research : AMRI Names Joseph D. Sangregorio as Senior Vice President and Chief Human Resources Off...	02/10/17	PU
Albany Molecular Research : AMRI Assembles a Comprehensive Medical Device Expert Solutions Team	21/09/17	PU
Albany Molecular Research : AMRI’s John Iannone Named US Expert to ISO Technical Committee	13/09/17	PU
3ST Research : Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)	12/09/17	PR
Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information	14/06/17	BU
WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders	09/06/17	PR
Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information	07/06/17	BU
Albany Molecular Research : Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research	07/06/17	PR
ALBANY MOLECULAR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albany Molecular Research, Inc.	07/06/17	PR
AMRI : Announces First Quarter 2017 Results	09/05/17	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Albany Molecular Research, Inc.

Actions

US0124231095

Communiqués

Filtres